The 2nd International Congress on Clinical Trials for Medical Devices (CTMD2016)

CTMD2016 will focus on the latest developments and upcoming regulations on clinical trials for medical devices in the EU and the US as well as in Brazil, Russia, India and China (BRIC countries) and the Oceania region.

LOK representatives from Israel, Brazil, India, China and Europe will be attending at CTMD2016, and we are happy to announce you that you will have a chance to meet them and ask your questions!

If you would like to schedule a meeting with one of our representatives, please contact us 

For more details regarding the upcoming event, please visit the congress website: 

Russia: Deadlines for the Procedure of Administrative Replacement of Registration Certificates

There are less than five months left until the deadline set by the Russian government in 2012 for the procedure of administrative replacement of “old” registration certificates for medical devices that were issued before 2013. According to Roszdravnadzor (the Russian medical device regulator), less than 9.2 thousand files for replacement have been submitted to authorities by medical device manufacturers since 2013 (out of the 37.5 thousand registration certificates which require replacement). Some experts say that this situation can lead to a problem where a significant number of medical devices may lose their approval in the Russian market from January 2017.

In the same time, the new Eurasian medical device regulation model requires medical device manufacturers to re-register their products by the end of 2021, according to the new Eurasian registration procedure.

Considering this, IMEDA (International Medical Device Manufacturers Association) sent a petition to the Ministry of Health of Russia with the suggestion to extend deadlines for the replacement of “old” registration certificates until the end of 2021.

Later in August, Roszdravnadzor issued a news release pointing out that the procedure for the replacement of registration certificates takes 30 days, and that today “medical device manufacturers have enough time to get new registration certificates.” determining that the statements about potential problems on the medical device market in 2017 stemming from bureaucratic reasons were “baseless.”


SoClean at Medica 2016

31 August 2016 – SoClean Inc. (Massachusetts, USA), a medical device company focused on improving the health and quality of life for those who suffer from obstructive sleep apnea (OSA) and other sleep disorders, will be present at Medica 2016 Hall 17 stand ???

If you would like to meet with SoClean management at or around this event, please contact the event organizers at 

About SoClean

The world’s first automated CPAP cleaner and sanitizing machine introducing a faster, easier, more effective way to clean CPAP equipment. The SoClean CPAP cleaning unit kills 99.9% of CPAP germs and bacteria in your mask, hose and reservoir with no disassembly, no water, and no chemicals. It’s the safer, healthier way to breathe cleaner and have a better CPAP experience.

Further information about LOK Corporation can be found at

UDI compliance deadline

85% of manufacturers are not prepared for upcoming UDI compliance deadline

September 24th deadline requires labels and packages of Class II medical devices such as condoms, wheelchairs and pregnancy tests to bear UDI barcodes. Data on Class II devices also must be submitted to the FDA’s Global Unique Device Identification Database. The database will serve as a reference for every device on the market. Class III devices that are reused must also have a UDI.

Class II devices comprise about 43% of the market, according to the FDA. By September 24, 2017, Class III devices, which are used to sustain or support life, such as pacemakers and comprise about 10% of the market, will need to carry UDIs.

The deadlines are part of a seven-year rollout by the FDA to ensure medical-device manufacturers mark their products with unique identifiers that allow industry and the government to track device safety and efficacy.

Only 15% of medical device manufacturers are currently compliant with the next phase of regulation required for unique device identification under the Food and Drug Administration’s final rule, according to a report.

The survey polled approximately 120 medical device professionals responsible for regulatory and information technology labeling. It was conducted by Loftware, a software company, and USDM Life Sciences, a professional services firm.

The poll found that only about 50% of respondents felt their current barcode labeling software would meet UDI regulations and other evolving requirements. This is likely because more than 70% of manufacturers don’t have a single, standardized labeling software. About 50% of respondents admitted that they continue to struggle getting all of the necessary data on the label. Challenges with understanding and applying the regulation also affected 36% of respondents. An overwhelming majority, 93%, also reported that UDI requirements have had a major or noticeable impact on their existing labeling operations.

In a news release, Jay Crowley, USDM Life Sciences vice president of UDI Services and Solutions said, “I can’t stress enough the need to have your approach to UDI compliance be well thought through and thorough, well documented and well implemented in a way that’s going to provide a path forward that can grow and evolve with your organization.”

Manufacturers found to be non-compliant will lose their right to sell devices across state lines.

CMS and FDA advocate for device identifiers on claims forms

The heads of the CMS (Centers for Medicare & Medicaid Services) and the Food and Drug Administration want universal health insurance claims forms to include unique device identifiers. The UDI would improve post-market surveillance and provide for better value-based reimbursement based on device performance, they say.

CMS Administrator Andy Slavitt and FDA Commissioner Dr. Robert Califf wrote to the chair of the Accredited Standards Committee X12, or ASC X12, to ask that the organization add UDIs for implantable medical devices on claims forms. The letter reflects the FDA’s push to improve device evaluation and surveillance, as outlined in a JAMA editorial Monday co-written by Califf.

Proponents of the use of UDIs say they could more quickly identify dangerous devices, some of which in recent years have not been flagged until they hurt patients. Those pushing for the use in claims say they could inform population health by evaluating associated outcome data.

Manufacturers and distributors currently are implementing UDIs and electronic health records are being tweaked to allow providers to one day record unique device identifiers, but insurance claims forms had been the holdout. Some in the industry say the changes are costly because the technology to support the changes isn’t there.

ASC X12 will release the next version of the insurance claims form for public comment in December. That template will be released in 2021. The next update isn’t scheduled for another 10 years.

FIME 2016

It is a major event for key international healthcare industry professionals to meet, network and make business connections.
Our team will be at FIME 2016 among 10,000 visitors from around the world, as expected in this year.

We will be glad to meet you and discuss your business opportunities!

See you at FIME 2016


(ICMED) is the first home developed international class certification scheme for the medical devices in the country – is an initiative of Association of Indian Medical Device Industry (AIMED) in collaboration with the Quality Council of India (QCI) and the National Accreditation Board for Certification Bodies (NABCB).  

ICMED aims to enhance patient safety, to provide enhanced consumer protection along with much needed product credentials to manufacturers for instilling confidence among buyers and users. This Scheme is intended for significantly elimination trading of sub-standard products or devices of doubtful origins, a widespread and injurious phenomenon in the Indian market. 

For manufacturers, it aims to bring down the substantial time and cost-run to obtain globally accepted quality certification for Indian companies and eliminate the malpractices of sub-standard or fraudulent certification or quality audits, thereby ensuring substantial savings, enhanced credibility and increased competitiveness.

The Scheme has been launched with two levels of certification:

• ICMED 9000 certification which is ISO 9001 plus additional requirements;
• ICMED 13485 which is ISO 13485 plus additional requirements.


China’s 13th Five-Year Plan

 One of the key sectors targeted by the Plan is Health and Aged Care. The 13th Five Year Plan promotes the idea of a “Healthy China”, encouraging the participation of the private sector in the establishment of an integrated health and aged care system. Foreign investment is viewed favourably due to its ability to introduce international best practices in to the Chinese market.

The Plan details a number of key targets in the health and aged care space:

• Increase the number of qualified doctors and medical assistants to 2.5 per 1,000 persons;
• Increase the number of general practice doctors to 2 per 10,000 persons;
• Systematically train 500,000 resident doctors to adequate standards;
• Establish 1-2 public hospitals in each county;
• Maintain the proportion of urban and rural citizens with health insurance above 95%;
• Reduce premature mortality from critical chronic diseases by 10%;
• Reduce the infant mortality rate to 7.5%, the mortality rate for children under 5 years to 9.5%; and the mortality rate for childbirth to 18 per 100,000 persons.

Opportunities for international businesses in China

 As China’s demographics alter and its population becomes older and increasingly more urban, China’s growing middle class is beginning to demand higher quality health care. This trend is already generating opportunities for offshore service suppliers, and it is expected more opportunities for international providers offering packaged health, medical and leisure services. Others are likely to take advantage of specific policies, which encourage cross border investment – for example, China’s policy to allow Hong Kong entities to set up wholly-owned hospitals.

 The Plan also promotes the concept of “smart health care”. This covers a wide range of initiatives, including internet-based health information platforms and electronic health records. As expected, China’s demand for various types of technology and innovation in the health sector to increase, presenting a unique opportunity for foreign investors with expertise in advanced medical research and technology to provide system solutions for a growing Chinese market.